Login / Signup

Should Dehydroepiandrosterone Be Administered to Women?

Margaret E WiermanKatja Kiseljak-Vassiliades
Published in: The Journal of clinical endocrinology and metabolism (2022)
A 49-year-old woman with Addison's disease who is on low dose estrogen with cyclic progesterone therapy for menopausal symptoms returns for follow-up. She is on a stable glucocorticoid replacement strategy of hydrocortisone 10 mg in the morning and 5 mg in the early afternoon and fludrocortisone 0.05 mg each morning. She has read on the internet that additional therapy with DHEA may help her overall quality of life and libido. She asks whether she should add this therapy to her regimen and at what dose.
Keyphrases
  • low dose
  • polycystic ovary syndrome
  • high dose
  • type diabetes
  • healthcare
  • pregnant women
  • single molecule
  • bone marrow
  • insulin resistance
  • pregnancy outcomes